"I went to the doctor to have imaging done, and they found a massive tumor in my intestines. Life changed..." View Entire ...

Cats with a severe coronavirus disease experienced an immune system boost after treatment with an MSC therapy, opening translational avenues for humans.

Feline infectious peritonitis, or FIP, is a serious and historically fatal disease in cats caused by a coronavirus. It ...

Cutaneous squamous cell carcinoma (CSCC) is a type of cancer that develops in squamous skin cells and is typically caused by exposure to ultraviolet (UV) radiation.

Basal cell carcinoma was the skin cancer with the highest risk of development in patients with primary Merkel cell carcinoma, followed by squamous cell carcinoma and melanoma.

Muzic JG, Schmitt AR, Wright AC, et al. Incidence and trends of basal cell carcinoma and cutaneous squamous cell carcinoma: a population-based study in Olmsted County, Minnesota, 2000 to 2010.

Regeneron Pharmaceuticals announced promising results from the Phase 3 C-POST trial of Libtayo (cemiplimab), a PD-1 inhibitor for patients with high-risk cutaneous squamous cell carcinoma (CSCC ...

Alliance trial shows dual immunotherapy improves progression-free survival in advanced squamous cell skin cancer Avelumab plus cetuximab combination meets primary endpoint in phase II trial ...

Libtayo (cemiplimab), approved as treatment for advanced cases of squamous cell carcinoma of the skin, might soon have a role in the treatment of local cases of the disease. Results of a phase 3 trial ...

While skin cancer rates are growing in many parts of the world, experts disagree on whether this represents a true epidemic or overdiagnosis is a contributing factor.

in combination with platinum-containing chemotherapy for the first-line treatment of adults with unresectable or metastatic esophageal squamous cell carcinoma (ESCC) whose tumors express PD-L1 (≥1).